| 臺大學術典藏 |
2021-08-24T08:23:29Z |
Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan
|
Liu W.-D.; Tsai W.-C.; Hsu W.-T.; Shih M.-C.; Chen M.-Y.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Cheng A.; Lin K.-Y.; YU-SHAN HUANG; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy
|
Chen G.-J.; Sun H.-Y.; Chang S.-Y.; Cheng A.; YU-SHAN HUANG; Huang S.-H.; Huang Y.-C.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; Lin K.-Y.; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; YU-SHAN HUANG; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:27Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
YU-SHAN HUANG; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Sun H.-Y.; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:01:29Z |
Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients
|
Huang Y.-S.; CHIEH-KAI CHAN; Tsai M.-S.; Lee K.-Y.; Lin S.-W.; Chang S.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-23T23:47:19Z |
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression
|
Huang W.-C.; Huang C.-K.; Huang S.-H.; Lin S.-W.; Ou S.-T.; YI-TING CHEN; Chen Y.-W.; Chang S.-Y.; Liu W.-C.; Sun H.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T08:50:14Z |
Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia
|
Lai C.-C.; Lee K.-Y.; Lin S.-W.; Chen Y.-H.; HAN-YUEH KUO; Hung C.-C.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-08-20T07:38:58Z |
Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018
|
Tsai M.-J.; Sun H.-Y.; SZU-MIN HSIEH; Sheng W.-H.; Chuang Y.-C.; Huang Y.-S.; Huang S.-H.; Su L.-H.; Su Y.-C.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:38:58Z |
Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
|
Liu W.-D.; Hung C.-C.; Wang J.-T.; Tsai M.-J.; Kuo P.-H.; Chao T.-L.; SZU-MIN HSIEH; Sheng W.-H.; Chen Y.-C.; Chang S.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T07:38:57Z |
Participation in cancer screening among people living with HIV at a university hospital
|
Wu P.-Y.; Sun H.-Y.; Chen M.-Y.; Sheng W.-H.; SZU-MIN HSIEH; Chuang Y.-C.; Chang H.-Y.; Luo Y.-Z.; Zhang J.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:38:56Z |
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
|
Liu C.-H.; Sun H.-Y.; SZU-MIN HSIEH; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-08-20T07:25:54Z |
Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018
|
Tsai M.-J.; Sun H.-Y.; Hsieh S.-M.; Sheng W.-H.; YU-CHUNG CHUANG; Huang Y.-S.; Huang S.-H.; Su L.-H.; Su Y.-C.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:25:53Z |
Participation in cancer screening among people living with HIV at a university hospital
|
Wu P.-Y.; Sun H.-Y.; Chen M.-Y.; Sheng W.-H.; Hsieh S.-M.; YU-CHUNG CHUANG; Chang H.-Y.; Luo Y.-Z.; Zhang J.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:25:53Z |
Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV
|
Huang S.-H.; Huang W.-C.; Lin S.-W.; YU-CHUNG CHUANG; Sun H.-Y.; Chang S.-Y.; Kuo P.-H.; Wu P.-Y.; Liu W.-C.; Chiang C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T07:25:52Z |
Comparisons of Serologic Responses of Early Syphilis to Treatment with a Single-Dose Benzathine Penicillin?G Between HIV-Positive and HIV-Negative Patients
|
Lin K.-Y.; Yang C.-J.; Sun H.-Y.; YU-CHUNG CHUANG; Chang L.-H.; Liu W.-C.; Su Y.-C.; Chang S.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T07:10:56Z |
Participation in cancer screening among people living with HIV at a university hospital
|
Wu P.-Y.; HSIN-YUN SUN; Chen M.-Y.; Sheng W.-H.; Hsieh S.-M.; Chuang Y.-C.; Chang H.-Y.; Luo Y.-Z.; Zhang J.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:10:56Z |
Seroepidemiology of the human herpesvirus 8 infection among people living with HIV in Taiwan, 2014–2018
|
Tsai M.-J.; HSIN-YUN SUN; Hsieh S.-M.; Sheng W.-H.; Chuang Y.-C.; Huang Y.-S.; Huang S.-H.; Su L.-H.; Su Y.-C.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study
|
Liou B.-H.; HSIN-YUN SUN; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; Cheng A.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; the Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
Huang Y.-S.; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; HSIN-YUN SUN; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Incidence and impact of low-level viremia among people living with HIV who received protease inhibitor- or dolutegravir-based antiretroviral therapy
|
Chen G.-J.; HSIN-YUN SUN; Chang S.-Y.; Cheng A.; Huang Y.-S.; Huang S.-H.; Huang Y.-C.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:10:54Z |
Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV
|
Huang S.-H.; Huang W.-C.; Lin S.-W.; Chuang Y.-C.; HSIN-YUN SUN; Chang S.-Y.; Kuo P.-H.; Wu P.-Y.; Liu W.-C.; Chiang C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T07:10:54Z |
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
|
Liu C.-H.; HSIN-YUN SUN; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-08-20T07:10:54Z |
Meta-Analysis of Efficacy and Safety of Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Among People Living with HIV
|
Chen I.-W.; HSIN-YUN SUN; Hung C.-C. |
| 臺大學術典藏 |
2021-08-20T07:10:53Z |
Comparisons of Serologic Responses of Early Syphilis to Treatment with a Single-Dose Benzathine Penicillin?G Between HIV-Positive and HIV-Negative Patients
|
Lin K.-Y.; Yang C.-J.; HSIN-YUN SUN; Chuang Y.-C.; Chang L.-H.; Liu W.-C.; Su Y.-C.; Chang S.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-08-20T06:57:48Z |
Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19
|
Liu W.-D.; Hung C.-C.; JANN-TAY WANG; Tsai M.-J.; Kuo P.-H.; Chao T.-L.; Hsieh S.-M.; Sheng W.-H.; Chen Y.-C.; Chang S.-Y.; Chang S.-C. |
